Details for 2007752695
Up to date per 04.04.2026
Actions
Details for 2007752695
Granted/Registered
European Patent
10.12.2008 A
07.05.2014 B1
14.03.2006
US
782629 P
29.09.2006
US
848315 P
07.12.2006
US
636293
A61K 31/56 20060101AFI20111111BHEP
Owner
CLS Pharmaceuticals, Inc.168 Second Avenue, Suite 331 New York NY 10003US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
SAMSON, C., Michael630 First Avenue, 25K New York, NY 10016US
LIANG, Bo239 Bromley place East Brunswick, NJ 08816US
CAPRIOTTI, Joseph, A.321 East 13th Street, Apt. 13G New York, NY 10003US
Information about Fees